PERTH, Australia and NEW YORK, New York – May 26, 2021 – PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced it will participate as one of a select group of companies at the upcoming Evercore ISI GenomeRx Emerging Therapeutic Company Day, taking place virtually on June 3. Evercore ISI is a leading healthcare investment bank in the U.S.
4 days prior to the TH.
I kept adding to my portfolio ever since.
Previous results and updates from company pionting towards successful data, hence the investment bank interest.
all IMO
PYC Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)